Neuronetics Stock Soars 7.25% on Institutional Investments
On August 13, 2025, Neuronetics' stock surged by 7.25% in pre-market trading, reflecting a significant uptick in investor interest and confidence in the company's prospects.
Madryn Asset Management, LP reported a beneficial ownership of 20,737,061 shares of NeuroneticsSTIM--, Inc. (STIM), representing 31.4% of the total shares. This disclosure included details of Rule 144 sales on August 8, 2025, at approximately $3.72 per share, indicating a strategic move by the firm to manage its holdings.
Citizens Financial Group Inc. made a notable investment in Neuronetics, acquiring 83,000 shares worth $305,000, which represents 0.13% of the company's total shares. This investment underscores the growing institutional interest in Neuronetics' potential for growth and innovation in the neurohealth sector.
Get the scoop on pre-market movers and shakers in the US stock market.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments
No comments yet